Sara Costain
Appearance
Sara Costain | |
---|---|
Entrepreneur | |
AS | |
![]() Sara Costain in 2034 | |
Co-Founder of FocalSpace | |
In Office | 5 Jan 2030 - Present |
Industry | Real estate |
Co-founder | TBD |
Funding | $11.6 million (Series B, 2033) $5 million (Series A, 2031) |
Equity | 78.0% |
Vice President of the Andromeda Sorority | |
In Office | TBD |
Patron | Julian Kao |
President | TBD |
Preceded by | Position created |
Succeeded by | TBD |
1st Veloria of the House of Juno | |
In Office | 20 Feb 2018 - 21 Nov 2021 |
Patron | Julian Kao |
Chief of Staff | TBD |
Preceded by | Position created |
Succeeded by | Zhao Jie |
Consort of the House of Juno | |
Patron | Julian Kao |
Chief of Staff | TBD |
Veloria | Herself |
Admission | 8 November 2017 |
Maturity | 21 November 2021 |
Preceded by | Position created |
Succeeded by | Taylor Benteke |
Personal Information | |
Born | 20 November 1996 (age 38) Douglas, Isle of Man United Kingdom |
Nationality | ![]() |
Height | 174 cm (5'9") |
Breasts | 32B |
Hair | Brown |
Eyes | Brown |
Dress Size | 6 |
Education | Parsons School of Design (BA) |
Jessica Kristin Stroud, PhD (born 6 June 1999) is an American entrepreneur, scientist and philanthropist who has been serving since 5 January 2030 as Chief Executive Officer of Nimbus Therapeutics Inc., the company she co-founded alongside TBD and TBD. Previously, she worked at Impossible Foods, Inc. from 2026 to 2030, rising to become the director of the company's global research center in April 2029. She has also been a trustee of the Kao Foundation since 16 February 2032, and is known for frequently championing environmental and social causes.